STAT News

STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down

Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.

By STAT News

1 min read
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights